These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3011261)

  • 61. Evaluation of a new drug 7-N-(p-hydroxyphenyl)-mitomycin C [KW 2083] against carcinoma of the lung by the human tumor clonogenic assay.
    Kanzawa F; Matsushima Y; Hoshi A; Shimizu E; Saijo N; Miyazawa N
    Invest New Drugs; 1985; 3(4):341-7. PubMed ID: 3003004
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Streptozotocin: an inactive agent in small cell carcinoma.
    Maurer LH; Weiss RB; Aisner J
    Cancer Clin Trials; 1979; 2(1):59-61. PubMed ID: 229984
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase II trial of streptozotocin for small cel anaplastic carcinoma of the lung.
    Kane RC; Bernath AM; Cashdollar MR
    Cancer Treat Rep; 1978 Mar; 62(3):477-8. PubMed ID: 206360
    [No Abstract]   [Full Text] [Related]  

  • 64. Identification of new drugs in small cell lung cancer: phase II agents first?
    Aisner J
    Cancer Treat Rep; 1987 Dec; 71(12):1131-3. PubMed ID: 2825989
    [No Abstract]   [Full Text] [Related]  

  • 65. Histologic subtypes of small cell carcinoma of the lung: response to therapy.
    Davis S; Sobel H
    Eur J Cancer (1965); 1981 Mar; 17(3):351-4. PubMed ID: 6266835
    [No Abstract]   [Full Text] [Related]  

  • 66. Ledakrin in treatment of patients with carcinoma of the lung.
    Kwaśniewska-Rokicińska C; Drosik K
    Mater Med Pol; 1983; 15(1-2):43-6. PubMed ID: 6672480
    [No Abstract]   [Full Text] [Related]  

  • 67. Small cell carcinoma of the lung. Clinicopathological studies.
    Takita H; Brugarolas A; Marabella P; Vincent RG
    J Thorac Cardiovasc Surg; 1973 Sep; 66(3):472-7. PubMed ID: 4354771
    [No Abstract]   [Full Text] [Related]  

  • 68. Acute leukemia following intensive therapy for small-cell carcinoma of the lung.
    Markman M; Pavy MD; Abeloff MD
    Cancer; 1982 Aug; 50(4):672-5. PubMed ID: 6284336
    [No Abstract]   [Full Text] [Related]  

  • 69. Local erythema multiforme-like drug reaction following intravenous mitomycin C and 5-fluorouracil.
    Spencer HJ
    J Surg Oncol; 1984 May; 26(1):47-50. PubMed ID: 6328125
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinico-pathological studies of resected cases of giant cell carcinoma of the lung].
    Ito M; Aoki M; Takashima Y; Mitsuoka A; Taki T; Teramatsu T
    Nihon Kyobu Geka Gakkai Zasshi; 1983 Aug; 31(8):1258-62. PubMed ID: 6315832
    [No Abstract]   [Full Text] [Related]  

  • 71. Phase II study of vincristine infusion in refractory small cell carcinoma of the lung.
    Jackson DV; Pope EK; Hire EA; Spurr CL; Rardin DA; McCulloch J
    Am J Clin Oncol; 1985 Apr; 8(2):154-6. PubMed ID: 3010697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phase II trials of small-cell lung cancer.
    Korn EL; Simon R; Friedman MA; Moore TD
    J Clin Oncol; 1992 Aug; 10(8):1369-70. PubMed ID: 1321895
    [No Abstract]   [Full Text] [Related]  

  • 73. Phase II study of high-dose aclarubicin in previously treated patients with small-cell lung cancer.
    Jensen PB; Larsen SK; Stilbo I
    Cancer Chemother Pharmacol; 1992; 30(3):219-20. PubMed ID: 1321008
    [No Abstract]   [Full Text] [Related]  

  • 74. Phase II study of sulofenur (LY186641) in untreated patients with extensive small cell lung cancer.
    Shepherd FA; MacCormick R; Eisenhauer EA
    Ann Oncol; 1991; 2(10):772-3. PubMed ID: 1666298
    [No Abstract]   [Full Text] [Related]  

  • 75. Laetrile toxicity: a report of two patients.
    Smith FP; Butler TP; Cohan S; Schein PS
    Cancer Treat Rep; 1978 Jan; 62(1):169-71. PubMed ID: 203395
    [No Abstract]   [Full Text] [Related]  

  • 76. Revisiting the debate: the use of new agents in previously untreated patients with small cell lung cancer; quality versus duration of survival.
    Markman M
    J Cancer Res Clin Oncol; 1994; 120(12):693-4. PubMed ID: 7798291
    [No Abstract]   [Full Text] [Related]  

  • 77. [Selective bronchial arteriography and therapeutic infusion].
    Li LS
    Zhonghua Yi Xue Za Zhi; 1986 Apr; 66(4):214-6, 254. PubMed ID: 3094876
    [No Abstract]   [Full Text] [Related]  

  • 78. Growth kinetics of small cell carcinoma of the lung.
    Lenhard RE; Woo KB; Freund JS; Abeloff MD
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):899-904. PubMed ID: 6276183
    [No Abstract]   [Full Text] [Related]  

  • 79. [Potentiation of mitomycin C by dextran sulfate].
    Niitani H; Taniguchi T; Konda C; Suzuki A; Kimura K
    Gan No Rinsho; 1971; 17(9):700-3. PubMed ID: 5165864
    [No Abstract]   [Full Text] [Related]  

  • 80. Phase II study of pirarubicin in untreated metastatic small cell lung carcinoma. Groupe Français de Pneumo-Cancérologie (GFPC).
    Kleisbauer JP; Vergeret J; Balmes P; Reynaud-Gaubert M; Taytard A; Targhetta R; Thomas P; Bonnaud F; Poirier R
    Eur J Cancer; 1991; 27(7):943. PubMed ID: 1657080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.